STOCK ALARM
PRO
SA
PRO
News
Screener
Rankings
Alerts
Earnings
Research
More
Pro
Sign In
Free Account
Themes
VYNE Therapeutics Inc.
VYNE
NASDAQ
Loading
Overview
Intelligence
Charts
News
Fundamentals
Key Metrics
Financials
Growth
Insiders
Analysis
More
Key Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Loading chart...
As of
2025
• vs 2024
Annual
Quarterly
Core Metrics
Market Cap
$24.81M
-82.6%
P/E Ratio
-0.94
+73.8%
P/S Ratio
43.53
-84.7%
ROE
-95.38%
-24.7%
ROIC
-107.15%
-28.1%
FCF Yield
-133.51%
-458.8%
Debt/Equity
0.00
Current Ratio
12.53
+188.2%
Interest Coverage
0.00x
Per Share
Revenue/Share
$0.01
+13.3%
Net Income/Share
$-0.62
+33.8%
Operating CF/Share
$-0.77
+2.9%
Free CF/Share
$-0.77
+3.2%
Cash/Share
$0.68
-53.0%
Book Value/Share
$0.65
-46.9%
Tangible Book/Share
$0.65
-46.9%
Equity/Share
$0.65
-46.9%
Interest Debt/Share
$0.00
Valuation
Market Cap
$24.81M
-82.6%
Enterprise Value
$782.72K
-99.4%
P/E Ratio
-0.94
+73.8%
P/S Ratio
43.53
-84.7%
P/OCF Ratio
-0.75
+82.2%
P/FCF Ratio
-0.75
+82.1%
P/B Ratio
0.89
-67.4%
P/TB Ratio
0.89
-67.4%
EV/Sales
1.37
-99.4%
EV/EBITDA
-0.03
+99.0%
Profitability
Earnings Yield
-106.74%
-282.3%
FCF Yield
-133.51%
-458.8%
ROE
-95.38%
-24.7%
ROIC
-107.15%
-28.1%
Return on Tangible Assets
-87.81%
-47.5%
Capital Allocation
CapEx/OCF
0.00%
CapEx/Revenue
0.00%
CapEx/Depreciation
0.00
SBC/Revenue
404.91%
-38.6%
Balance Sheet
Debt/Equity
0.00
Debt/Assets
0.00
Net Debt/EBITDA
0.90
+97.8%
Current Ratio
12.53
+188.2%
Interest Coverage
0.00x
Income Quality
1.25
+46.7%
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$0.62
-43.2%